Spots Global Cancer Trial Database for Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors
Official Title:
Study ID: NCT00317928
Conditions
Interventions
Study Description
Brief Summary: Hypothesis: Metformin treatment normalises hormone values and metabolic parameters in women with PCOS. Ovulation is restored and bleeding periods become regular. Fifty women with PCOS (Rotterdam criteria) are randomised to either placebo or metformin for 6 months. After a wash-out period of 3 months, the opposite treatment is given for another 6 months. Measurements are performed before ech treatment period, every second month during treatment and after completing treatment.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Name: Ditte Trolle, MD
Affiliation: Skejby University Hospital, Aarhus, Denmark
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
